{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:07:09Z","timestamp":1761934029937,"version":"build-2065373602"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006668","name":"OHSU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.iccl.2023.11.001","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T03:50:34Z","timestamp":1705809034000},"page":"167-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional Mitral Regurgitation"],"prefix":"10.1016","volume":"13","author":[{"given":"Pooja","family":"Prasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranav","family":"Chandrashekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsh","family":"Golwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad J.","family":"Macon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.iccl.2023.11.001_bib1","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.echo.2006.06.009","article-title":"High prevalence of clinically silent severe mitral regurgitation in patients with heart failure: role for echocardiography","volume":"19","author":"Varadarajan","year":"2006","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.iccl.2023.11.001_bib2","doi-asserted-by":"crossref","first-page":"n1421","DOI":"10.1136\/bmj.n1421","article-title":"Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study","volume":"373","author":"Bartko","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.iccl.2023.11.001_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/24748706.2020.1765055","article-title":"Pathoanatomy of mitral regurgitation","volume":"4","author":"Karagodin","year":"2020","journal-title":"Struct Heart"},{"issue":"3","key":"10.1016\/j.iccl.2023.11.001_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/CIRCULATIONAHA.116.025260","article-title":"Exercise dynamics in secondary mitral regurgitation: pathophysiology and therapeutic implications","volume":"135","author":"Bertrand","year":"2017","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.iccl.2023.11.001_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/eurheartj\/ehab086","volume":"42","author":"Coats","year":"2021","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.iccl.2023.11.001_bib6","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/jamacardio.2020.2236","article-title":"Not all secondary mitral regurgitation is the same-potential phenotypes and implications for mitral repair","volume":"5","author":"Reddy","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2023.11.001_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.amjmed.2005.08.025","article-title":"Mitral regurgitation after myocardial infarction: a review","volume":"119","author":"Bursi","year":"2006","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.iccl.2023.11.001_bib8","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.jcmg.2022.08.016","article-title":"Atrial functional mitral regurgitation: a JACC: cardiovascular imaging expert panel viewpoint","volume":"15","author":"Zoghbi","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.iccl.2023.11.001_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.euje.2004.10.010","article-title":"Underestimation of severity of mitral regurgitation with varying hemodynamics","volume":"6","author":"Scholte","year":"2005","journal-title":"Eur J Echocardiogr"},{"issue":"2","key":"10.1016\/j.iccl.2023.11.001_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0002-9149(99)00644-X","article-title":"Effect of general anesthesia on the severity of mitral regurgitation by transesophageal echocardiography","volume":"85","author":"Grewal","year":"2000","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.iccl.2023.11.001_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the american society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"19","key":"10.1016\/j.iccl.2023.11.001_bib12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jaccas.2022.07.013","article-title":"An integrative, multiparametric approach to mitral regurgitation evaluation: a case-based illustration","volume":"4","author":"Faza","year":"2022","journal-title":"JACC Case Rep"},{"issue":"5","key":"10.1016\/j.iccl.2023.11.001_bib13","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.iccl.2023.11.001_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.iccl.2023.11.001_bib15","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/eurheartj\/ehi189","article-title":"Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation","volume":"26","author":"Lancellotti","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2023.11.001_bib16","doi-asserted-by":"crossref","first-page":"e01","DOI":"10.15420\/icr.2020.17","article-title":"Exercise right heart catheterisation in cardiovascular diseases: a guide to interpretation and considerations in the management of valvular heart disease","volume":"16","author":"Valle","year":"2020","journal-title":"Interv Cardiol"},{"issue":"9","key":"10.1016\/j.iccl.2023.11.001_bib17","doi-asserted-by":"crossref","first-page":"e009689","DOI":"10.1161\/CIRCHEARTFAILURE.122.009689","article-title":"Medical therapy for functional mitral regurgitation","volume":"15","author":"Milwidsky","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.iccl.2023.11.001_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jacc.2020.05.079","article-title":"Effectiveness of medical therapy for functional mitral regurgitation in heart failure with reduced ejection fraction","volume":"76","author":"Sannino","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.iccl.2023.11.001_bib19","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.iccl.2023.11.001_bib20","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.iccl.2023.11.001_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.iccl.2023.11.001_bib22","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.iccl.2023.11.001_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCULATIONAHA.120.052926","article-title":"How should we sequence the treatments for heart failure and a reduced ejection fraction?: a redefinition of evidence-based medicine","volume":"143","author":"McMurray","year":"2021","journal-title":"Circulation"},{"issue":"10367","key":"10.1016\/j.iccl.2023.11.001_bib24","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.iccl.2023.11.001_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/hrt.72.1.63","article-title":"Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial","volume":"72","author":"Seneviratne","year":"1994","journal-title":"Br Heart J"},{"issue":"11","key":"10.1016\/j.iccl.2023.11.001_bib26","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","article-title":"Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation","volume":"139","author":"Kang","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.iccl.2023.11.001_bib27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0002-8703(00)90036-X","article-title":"Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol","volume":"139","author":"Capomolla","year":"2000","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.iccl.2023.11.001_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0041-1345(01)02717-8","article-title":"Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction","volume":"34","author":"Comin-Colet","year":"2002","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.iccl.2023.11.001_bib29","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(99)00059-4","article-title":"Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure","volume":"83","author":"Lowes","year":"1999","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.iccl.2023.11.001_bib30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/hrt.2002.009696","article-title":"The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter","volume":"90","author":"Kotlyar","year":"2004","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.iccl.2023.11.001_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamacardio.2020.0640","article-title":"Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the guide-it trial: a secondary analysis of a randomized clinical trial","volume":"5","author":"Fiuzat","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"Suppl 3","key":"10.1016\/j.iccl.2023.11.001_bib32","article-title":"CRT and exercise capacity in heart failure: the impact of mitral valve regurgitation","volume":"10","author":"Parthenakis","year":"2008","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.iccl.2023.11.001_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ehjci\/jev352","article-title":"Role of cardiac dyssynchrony and resynchronization therapy in functional mitral regurgitation","volume":"17","author":"Spartera","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"21","key":"10.1016\/j.iccl.2023.11.001_bib34","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.jacc.2011.06.061","article-title":"Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling","volume":"58","author":"Auricchio","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12 Suppl 1","key":"10.1016\/j.iccl.2023.11.001_bib35","doi-asserted-by":"crossref","first-page":"I68","DOI":"10.1161\/hc37t1.094706","article-title":"Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation?","volume":"104","author":"Aklog","year":"2001","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.iccl.2023.11.001_bib36","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.amjcard.2014.07.012","article-title":"Outcomes of patients with ischemic mitral regurgitation undergoing percutaneous coronary intervention","volume":"114","author":"Yousefzai","year":"2014","journal-title":"Am J Cardiol"},{"issue":"20","key":"10.1016\/j.iccl.2023.11.001_bib37","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.iccl.2023.11.001_bib38","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.jacc.2019.02.061","article-title":"Atrial functional mitral regurgitation: JACC review topic of the week","volume":"73","author":"Deferm","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9851","key":"10.1016\/j.iccl.2023.11.001_bib39","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.iccl.2023.11.001_bib40","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.iccl.2023.11.001_bib41","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the american college of cardiology solution set oversight committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.iccl.2023.11.001_bib42","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jacc.2011.06.032","article-title":"Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control","volume":"58","author":"Gertz","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.iccl.2023.11.001_bib43","doi-asserted-by":"crossref","first-page":"e009317","DOI":"10.1161\/CIRCIMAGING.119.009317","article-title":"Reverse remodeling of the mitral valve complex after radiofrequency catheter ablation for atrial fibrillation: a serial 3-dimensional echocardiographic study","volume":"12","author":"Nishino","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"issue":"27","key":"10.1016\/j.iccl.2023.11.001_bib44","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/eurheartj\/ehz306","article-title":"Impact of recurrent mitral regurgitation after mitral valve repair for functional mitral regurgitation: long-term analysis of competing outcomes","volume":"40","author":"Petrus","year":"2019","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.iccl.2023.11.001_bib45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMoa1512913","article-title":"Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation","volume":"374","author":"Goldstein","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.iccl.2023.11.001_bib46","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","article-title":"What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?","volume":"28","author":"Mirabel","year":"2007","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.iccl.2023.11.001_bib47","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.iccl.2023.11.001_bib48","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.jcin.2022.09.005","article-title":"Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients","volume":"15","author":"Lim","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"10.1016\/j.iccl.2023.11.001_bib49","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMoa1602003","article-title":"Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation","volume":"374","author":"Michler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2023.11.001_bib50","unstructured":"FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation [Internet]. FDA. 2019, Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-indication-valve-repair-device-treat-certain-heart-failure-patients-mitral."},{"issue":"22","key":"10.1016\/j.iccl.2023.11.001_bib51","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa2300213","article-title":"Five-year follow-up after transcatheter repair of secondary mitral regurgitation","volume":"388","author":"Stone","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.iccl.2023.11.001_bib52","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jcin.2023.05.013","article-title":"Real-world outcomes of fourth-generation mitral transcatheter repair: 30-day results From EXPAND G4","volume":"16","author":"von Bardeleben","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.iccl.2023.11.001_bib53","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.4244\/EIJ-D-21-00012","article-title":"Incidence and standardised definitions of mitral valve leaflet adverse events after transcatheter mitral valve repair: the EXPAND study","volume":"17","author":"Asch","year":"2021","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.iccl.2023.11.001_bib54","doi-asserted-by":"crossref","first-page":"e010895","DOI":"10.1161\/CIRCINTERVENTIONS.121.010895","article-title":"Recurrent mitral regurgitation after mitraclip: predictive factors, morphology, and clinical implication","volume":"15","author":"Sugiura","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2023.11.001_bib55","unstructured":"Institut fuer anwendungsorientierte Forschung und klinische Studien Gmb H. A RandomizEd Study of tHe MitrACliP DEvice in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation [Internet]. 2021. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02444338."},{"issue":"23","key":"10.1016\/j.iccl.2023.11.001_bib56","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2021.07.058","article-title":"Transcatheter mitral valve therapy in the united states: a report from the STS-ACC TVT registry","volume":"78","author":"Mack","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2023.11.001_bib57","unstructured":"Abbott Medical D. A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip\u00ae Devices (EXPAND). Clinical trial registration. clinicaltrials.gov; 2021 2021\/12\/07\/. Report No.: study\/NCT03502811."},{"issue":"15","key":"10.1016\/j.iccl.2023.11.001_bib58","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/CIR.0b013e31824f2173","article-title":"Decision making in advanced heart failure: a scientific statement from the American Heart Association","volume":"125","author":"Allen","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.iccl.2023.11.001_bib59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cardfail.2021.07.012","article-title":"Hemodynamics for the heart failure clinician: a state-of-the-art review","volume":"28","author":"Hsu","year":"2022","journal-title":"J\u00a0Card Fail"},{"issue":"8","key":"10.1016\/j.iccl.2023.11.001_bib60","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jchf.2016.03.022","article-title":"Cardiopulmonary exercise testing in heart failure","volume":"4","author":"Malhotra","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.iccl.2023.11.001_bib61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijcard.2018.10.055","article-title":"Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment","volume":"284","author":"Baldi","year":"2019","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2023.11.001_bib62","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ahj.2008.07.010","article-title":"A\u00a0cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure","volume":"156","author":"Myers","year":"2008","journal-title":"Am Heart J"},{"issue":"13","key":"10.1016\/j.iccl.2023.11.001_bib63","doi-asserted-by":"crossref","first-page":"e029735","DOI":"10.1161\/JAHA.123.029735","article-title":"Acute reduction in left ventricular function following transcatheter mitral edge-to-edge repair","volume":"12","author":"Perl","year":"2023","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.iccl.2023.11.001_bib64","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.healun.2020.09.005","article-title":"MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry","volume":"39","author":"Godino","year":"2020","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"20","key":"10.1016\/j.iccl.2023.11.001_bib65","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jcin.2020.06.058","article-title":"NYHA functional classification and outcomes after transcatheter mitral valve repair in heart failure: The COAPT trial","volume":"13","author":"Giustino","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.iccl.2023.11.001_bib66","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jcin.2023.01.362","article-title":"Impact of transcatheter edge-to-edge mitral valve repair on guideline-directed medical therapy uptitration","volume":"16","author":"Adamo","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"10.1016\/j.iccl.2023.11.001_bib67","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jcin.2021.07.047","article-title":"Right ventricular-pulmonary arterial coupling in patients with hf secondary MR: analysis from the COAPT trial","volume":"14","author":"Brener","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"22","key":"10.1016\/j.iccl.2023.11.001_bib68","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.jacc.2020.09.609","article-title":"Pulmonary hypertension in transcatheter mitral valve repair for secondary mitral regurgitation: The COAPT trial","volume":"76","author":"Ben-Yehuda","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2023.11.001_bib69","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/joic.12566","article-title":"Impact of right heart function on outcome in patients with functional mitral regurgitation and chronic heart failure undergoing percutaneous edge-to-edge-repair","volume":"31","author":"Osteresch","year":"2018","journal-title":"J\u00a0Interv Cardiol"},{"issue":"15","key":"10.1016\/j.iccl.2023.11.001_bib70","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jcin.2020.03.025","article-title":"Predictors of outcomes following transcatheter edge-to-edge mitral valve repair","volume":"13","author":"Ben-Shoshan","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.iccl.2023.11.001_bib71","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jacc.2020.07.035","article-title":"Impact of tricuspid regurgitation on clinical outcomes: The COAPT trial","volume":"76","author":"Hahn","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.iccl.2023.11.001_bib72","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.jcmg.2019.11.008","article-title":"Prognostic impact of ischemic mitral regurgitation severity and myocardial infarct quantification by cardiovascular magnetic resonance","volume":"13","author":"Cavalcante","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.iccl.2023.11.001_bib73","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The seattle heart failure model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.iccl.2023.11.001_bib74","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1161\/CIR.0000000000001016","article-title":"Guidance for timely and appropriate referral of patients with advanced heart failure: a scientific statement from the american heart association","volume":"144","author":"Morris","year":"2021","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.iccl.2023.11.001_bib75","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.jacc.2021.10.011","article-title":"Outcomes stratified by adapted inclusion criteria after mitral edge-to-edge repair","volume":"78","author":"Koell","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2023.11.001_bib76","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jcmg.2018.11.006","article-title":"Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials","volume":"12","author":"Grayburn","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.iccl.2023.11.001_bib77","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.amjcard.2021.08.062","article-title":"Clinical and hemodynamic effects of percutaneous edge-to-edge mitral valve repair in atrial versus ventricular functional mitral regurgitation","volume":"161","author":"Claeys","year":"2021","journal-title":"Am J Cardiol"},{"issue":"21","key":"10.1016\/j.iccl.2023.11.001_bib78","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.jcin.2023.09.029","article-title":"1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study","volume":"16","author":"von Bardeleben","year":"2023","journal-title":"J Am Coll Cardiol Intv"},{"issue":"2","key":"10.1016\/j.iccl.2023.11.001_bib79","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/ehf2.14273","article-title":"Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: Results from the global EXPAND study","volume":"10","author":"Shuvy","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"36","key":"10.1016\/j.iccl.2023.11.001_bib80","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.iccl.2023.11.001_bib81","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.jacc.2022.09.006","article-title":"Transcatheter edge-to-edge mitral valve repair in patients with severe mitral regurgitation and cardiogenic shock","volume":"80","author":"Simard","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2023.11.001_bib82","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ahj.2022.08.008","article-title":"Transcatheter mitral valve repair for inotrope dependent cardiogenic shock - Design and rationale of the CAPITAL MINOS trial","volume":"254","author":"Parlow","year":"2022","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.iccl.2023.11.001_bib83","doi-asserted-by":"crossref","first-page":"e012486","DOI":"10.1161\/CIRCINTERVENTIONS.122.012486","article-title":"Contemporary anatomic criteria and clinical outcomes with transcatheter mitral repair","volume":"16","author":"Sorajja","year":"2023","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745823000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745823000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:02:21Z","timestamp":1761933741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745823000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2211745823000913"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2023.11.001","relation":{},"ISSN":["2211-7458"],"issn-type":[{"type":"print","value":"2211-7458"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Mitral Regurgitation","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2023.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}